Wave Life Sciences Stock Performance
| WVE Stock | USD 15.10 0.11 0.73% |
Wave Life holds a performance score of 13 on a scale of zero to a hundred. The firm maintains a market beta of 3.49, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Wave Life will likely underperform. Use Wave Life Sciences semi variance, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on Wave Life Sciences.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.73 | Five Day Return 2.86 | Year To Date Return 182.77 | Ten Year Return (5.62) | All Time Return (5.62) |
1 | Wave Life Sciences Third Quarter 2024 Earnings Misses Expectations | 11/14/2024 |
2 | Kentucky Retirement Systems Insurance Trust Fund Sells 328 Shares of Revvity, Inc. | 11/19/2024 |
3 | Outdoor Power Equipment Market to Propel Growth at USD 76.61 Billion by 2031 SkyQuest Technology | 11/22/2024 |
4 | LOOPBACK ANALYTICS NAMED ONE OF THE DALLAS BUSINESS JOURNALS BEST PLACES TO WORK FOR 2024 | 11/25/2024 |
5 | Metal Forging Market is Poised to Grow at CAGR of 7.7 percent by 2031 SkyQuest Technology | 11/26/2024 |
6 | Viz.ai Collaborates with Microsoft to Advance AI-powered Clinical Workflows and Better Patient Care | 11/27/2024 |
7 | Glenmede Trust Co. NA Increases Stock Holdings in Agilent Technologies, Inc. | 11/29/2024 |
| Begin Period Cash Flow | 92.2 M |
Wave |
Wave Life Relative Risk vs. Return Landscape
If you would invest 555.00 in Wave Life Sciences on September 2, 2024 and sell it today you would earn a total of 955.00 from holding Wave Life Sciences or generate 172.07% return on investment over 90 days. Wave Life Sciences is generating 2.1268% of daily returns assuming volatility of 12.237% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Wave, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Wave Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wave Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Wave Life Sciences, and traders can use it to determine the average amount a Wave Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1738
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | WVE | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.24 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.13 actual daily | 42 58% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Wave Life is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wave Life by adding it to a well-diversified portfolio.
Wave Life Fundamentals Growth
Wave Stock prices reflect investors' perceptions of the future prospects and financial health of Wave Life, and Wave Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wave Stock performance.
| Return On Equity | -2.44 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (2.66) % | ||||
| Operating Margin | 8.33 % | ||||
| Current Valuation | 2.02 B | ||||
| Shares Outstanding | 152.52 M | ||||
| Price To Earning | (6.50) X | ||||
| Price To Book | 16.26 X | ||||
| Price To Sales | 42.96 X | ||||
| Revenue | 113.31 M | ||||
| Gross Profit | (73.64 M) | ||||
| EBITDA | (58.79 M) | ||||
| Net Income | (57.51 M) | ||||
| Cash And Equivalents | 148.16 M | ||||
| Cash Per Share | 1.71 X | ||||
| Total Debt | 32.12 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 2.50 X | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | (19.43 M) | ||||
| Earnings Per Share | (1.12) X | ||||
| Market Capitalization | 2.3 B | ||||
| Total Asset | 274.95 M | ||||
| Retained Earnings | (1.02 B) | ||||
| Working Capital | 48.93 M | ||||
| Current Asset | 161.38 M | ||||
| Current Liabilities | 3.82 M | ||||
About Wave Life Performance
By analyzing Wave Life's fundamental ratios, stakeholders can gain valuable insights into Wave Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Wave Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Wave Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.60 | 20.30 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.77) | (0.81) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (1.21) | (1.27) |
Things to note about Wave Life Sciences performance evaluation
Checking the ongoing alerts about Wave Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wave Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 78.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Glenmede Trust Co. NA Increases Stock Holdings in Agilent Technologies, Inc. |
- Analyzing Wave Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wave Life's stock is overvalued or undervalued compared to its peers.
- Examining Wave Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wave Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wave Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wave Life's stock. These opinions can provide insight into Wave Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |